financetom
Business
financetom
/
Business
/
Baker CEO says 2025 resilience driven by AI growth, sees oil investment slowdown
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Baker CEO says 2025 resilience driven by AI growth, sees oil investment slowdown
Oct 24, 2025 8:12 AM

Oct 24 (Reuters) - Baker Hughes ( BKR ) CEO Lorenzo

Simonelli said on Friday the global macro environment remains

resilient through 2025, despite geopolitical and policy

headwinds, supported by the rapid deployment of generative

artificial intelligence driving power demand and industrial

activity.

Simonelli said the company remains confident of reaching

$1.5 billion in data center orders ahead of its original

three-year target as it continues to see strong momentum in data

center power demand.

He, however, said Baker Hughes' ( BKR ) outlook for 2025 remains

unchanged, with a high-single-digit decline in global upstream

spending expected.

Simonelli cautioned that oversupply concerns in the oil

market were weighing on sentiment, with some OPEC+ members still

unable to meet production quotas. He said oil-related upstream

investment is expected to stay subdued until the market absorbs

the group's additional supply.

He said that early indicators suggest 2026 will be another

year of subdued activity and spending declines before a gradual

recovery takes hold, particularly in international and offshore

markets.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Eli Lilly's Zepbound Vs. Novo Nordisk's Wegovy - Which Shows Greater Weight Loss?
Eli Lilly's Zepbound Vs. Novo Nordisk's Wegovy - Which Shows Greater Weight Loss?
Dec 4, 2024
On Wednesday, Eli Lilly And Co ( LLY ) revealed topline data from the SURMOUNT-5 phase 3b trial evaluating the efficacy and safety of Zepbound (tirzepatide) compared with Novo Nordisk A/S’ Wegovy (semaglutide) in adults with obesity, or overweight with at least one of the following comorbidities: hypertension, dyslipidemia, obstructive sleep apnea or cardiovascular disease, who did not have diabetes.  Zepbound provided a 47%...
DocGo's Cardiac RMS Unit Signs Contract With Mississippi Hospital System
DocGo's Cardiac RMS Unit Signs Contract With Mississippi Hospital System
Dec 4, 2024
09:48 AM EST, 12/04/2024 (MT Newswires) -- DocGo ( DCGO ) said Wednesday that its Cardiac RMS subsidiary has signed a contract with an unnamed hospital system in Mississippi. Under the deal, DocGo's ( DCGO ) Cardiac RMS is scheduled to begin remote monitoring for nearly 3,000 patients with cardiac implantable electronic devices in early 2025. Financial terms were not...
Super Micro Computer Unusual Options Activity For December 04
Super Micro Computer Unusual Options Activity For December 04
Dec 4, 2024
Investors with a lot of money to spend have taken a bullish stance on Super Micro Computer ( SMCI ) . And retail traders should know. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know. But when something...
Crown Holdings to Receive $300 Million From Eviosys Stake Sale
Crown Holdings to Receive $300 Million From Eviosys Stake Sale
Dec 4, 2024
09:41 AM EST, 12/04/2024 (MT Newswires) -- Crown Holdings ( CCK ) said Wednesday it expects to receive about $300 million in net cash proceeds from the sale of its remaining 20% stake in Eviosys to Sonoco Products ( SON ) . Sonoco earlier said it had completed the acquisition of Eviosys from KPS Capital Partners. Crown's Chief Financial Officer...
Copyright 2023-2026 - www.financetom.com All Rights Reserved